Ophthalmic gene and cell therapies
In the field of ocular gene and cell therapy, tremendous progress has been made in both research and clinical testing. In the laboratory, researchers have uncovered potential new ways of treating glaucoma holistically by decreasing IOP and providing retinal and optic nerve neuroprotection. As we get a better understanding of the disease mechanisms, we will be able to target specific glaucoma disease pathways with gene and cell therapies in order to achieve safe, effective, and long-term vision loss prevention. Improved diagnostic tools such as high-resolution imaging and continuous tonometry will make it simpler to detect glaucoma early and obtain better treatment outcomes. Translation of innovative medicines from the laboratory to the clinical environment is a significant problem, particularly for veterinary ophthalmic applications, due to restricted resources for generating animal-specific drugs.